Benzinga
10 Apr 2026, 14:57 UTC · 23w ago
Verdict
Headline takes no side. We score OGN +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 86% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Sun Pharma is finalizing financing and moving toward a firm bid for the acquisition of Organon.
More positive than 98% of claims this week
Sun Pharma has completed a three-month due diligence process and mandated at least three global banks to support the transaction.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 91% of claims this week
Organon has been struggling with segment pressure and a significant debt burden, which it reduced to $8 billion in 2025.
More negative than 73% of claims this week
Which stocks this story touches
More positive than 86% of ticker scores this week
Shares surged nearly 28% on news that Sun Pharma is nearing a final offer for the company.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1d ago
—
No price for OGN right now — the quote feed didn't answer.
OGN chart →
